Margaret A. Shipp,Przemyslaw Juszczynski,Jing Ouyang,Jeffery Kutok,Scott Rodig,Gabriel Rabinovich
申请号：
US12175249
公开号：
US09939428B2
申请日:
2008.07.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in immune disorders, including Hodgkin lymphoma, anaplastic large cell lymphoma, or MLL+ pre B-cell ALL. Accordingly, the invention relates to compositions, kits, and methods for diagnosing, prognosing, and monitoring immune disorders, e.g., Hodgkin lymphoma, anaplastic large cell lymphoma, or MLL+ pre B-cell ALL.
